Presenter's Information
William F. Fearon, MD
| Country | USA |
| Specialty | Interventional Cardiologist |
- 3-Year Follow-Up of the FAME 3 Trial
- Update on the ALL-RISE Trial (Advancing Cath Lab Results With FFR-Angio Physiology Assessment)
- How I Use Angio-Based Physiology to Guide My Case in the Cath Lab: Practical Appraisal
- The Series of FAME Studies: A Paradigm Shift in Our Thinking About Interventional Cardiology
- Unmet Need for FFR in LM PCI
- True Message from FAME 3
- Role of PCI in Multivessel CAD: What Do the New Guidelines Say?
- FFR-Guided PCI for Multivessel CAD in 2022
- Angiography-derived Coronary Physiology
- Complete Revascularization for MVD and LM: Anatomic or Functional Concept
- Angio-guided vs. FFR-guided PCI
- FAME III: The Lessons from FAME Studies, What We Learned
- FAST FFR
- Many Pressure Wires in Cath Lab: Advantages and Disadvantages
- FAME 2: 3-year Clinical and Cost-effectiveness Outcomes of FFR-guided PCI in Patients with Coronary Artery Disease
- Non-Invasive FFR Assessment
- FFR Is Still Standard!
- Is Anatomic Complete Revascularization Really Necessary?
- PCI vs. CABG in LM and MVD: Time to Apply FFR for Decision-Making: Updated Data and FAME-3
- Post-PCI FFR: What Does It Mean and Should We Measure It?
- Are We Ready to Move from FFR to Resting Indices?
- The FUTURE Trial and Current Evidence of FFR Guided PCI: Is There Warning Sign?
- Routine Assessment of the Microcirculation and Absolute Flow: A Glimpse to the Future
- FFR Is Underutilized - Beyond Just Intermediate Lesions!
- Left Main
- Coronary Blood Flow, Pressure and Resistance: How to Integrate, Interpret and Apply in Practice
- Update on FAME 3 Trial
- Who Needs Adenosine or iFR, I Have cFFR (Contrast FFR): Update on the CONTRAST Study
- Invasive Evaluation of the Patient with Chest Pain and No Obstructive CAD
- Integrated Use of IMR and FFR in Daily Practice
- The Ultimate: FAME 3
- FFR State-of-the-Art: Clinical Applications and New Technologies
- MVD and FAME Studies
- Practical Set-up
- Update of the FAME 3 Trial
- Experimental Basis and Clinical Validation of FFR
- Assessment and Clinical Relevance of Coronary Microvasculature
- For Ischemia, Forget VP and Focus on the Ischemic Lesion!
- [FFR Use at CathLab: More & Better] Unmet Need: FAME 3
- FFR Clinical Trials: Review and Update
- FFR Evaluation: Optimal Measurement and Common Mistakes
- Clinical Benefit of FFR
- Tips and Trick
- How to Integrate FAME I, FAME II and COURAGE?
- Importance of the Coronary Microvasculature
- FFR in Acute Coronary Syndrome: Culprit and Non-culprit Lesion
- FAME2 & COURAGE Trials: Going Functional, It\'s Solution!
- Update 2013: FFR-guided Decision Making
- Roles of FFR in Unstable Angina and NSTEMI
- Clinical Application of IMR : Evidence and Practice
- Sidebranch Compromise: Mechanism and Implication
- How and Why to Assess the Coronary Microvasculature
- Gap Between Anatomy and Function
- FFR Clinical Trials and Applications: Make the PCI Practice Changed
- Beyond FAME: The Integration of Invasive Ischemia Assessment(FFR) into Clinical Practice
- When to Use IVUS and When Would FFR Be a Better Choice?
- FFR Guided PCI
- Integrated Decision Making in Bifurcation Lesion (IVUS vs. FFR)
- Practice Guideline for FFR Use (FAME Study)
- FFR in Multivessel Disease: Results of the F.A.M.E. Multicenter, International, Randomized Study Comparing FFR Guided PCI to Angio Guided PCI in Patients with Multivessel CAD
- Fundamentals, Techniques, Pitfalls, and Limitations of FFR Interpretation and Measurement
- Fractional Flow Reserve: Concept and Practical Set Up
- FFR-Guided PCI
- FFR in Multivessel Disease: Results of the F.A.M.E. Multicenter, International, Randomized Study Comparing FFR guided PCI to Angio guided PCI in Patients with Multivessel CAD
- Physiologic Assessment of Coronary Microvascular Dysfunction
- Physiologic Study and PCI
